+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurology Devices Market 2019-2025

  • ID: 5129643
  • Report
  • May 2020
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Dispomedica GmbH
  • Magstim Co. Ltd.
  • Möller Medical GmbH
  • NeuroPace, Inc.
  • MORE
Global Neurology Devices Market Size, Share & Trends Analysis Report, By Product (Cerebrospinal Fluid Management Devices, Neurostimulation Devices, Interventional Neurology Devices, Neurosurgery Devices, and Others), By End-User (Hospitals, Neurology Clinics, and Ambulatory Surgical Centers) and Forecast, 2019-2025.

The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson’s and Alzheimer’s disease has led the adoption of neurostimulation devices. In addition, rising spinal cord injuries are further encouraging the adoption of spinal cord stimulation (SCS) devices. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. SCS is normally used for the treatment of chronic pain in the limbs and trunk; however, it can also support enhance control and improve stiff or rigid muscles after a spinal cord injury. Therefore, the demand for spinal cord stimulation may be significantly used to treat spinal cord injuries.

Geographically, the market is classified into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2018, North America is anticipated to hold significant share in the market owing to the increasing number of neurosurgeries coupled with the significant prevalence of neurological disorders in the region. Asia-Pacific is estimated to witness considerable growth during the forecast period owing to the rising ageing population and associated neurological disorders in the region. In addition, increasing awareness regarding neurological disorders will further accelerate the number of neurosurgeries, which thereby will drive the adoption of neurology devices in the region.

Some crucial players operating in the market include Medtronic plc, Abbott Laboratories, Boston Scientific Corp., B. Braun Melsungen AG, and Stryker Corp. Mergers and acquisitions and product launches are some crucial strategies adopted by the market players to expand market share and gain a competitive advantage. For instance, in January 2020, Medtronic plc declared the acquisition of Stimgenics, LLC, a provider of novel spinal cord stimulation (SCS) waveform which is known as Differential Target Multiplexed (DTM) SCS. The therapy, which is delivered through the Medtronic Intellis platform, is a new and unique programming option for the treatment of patients suffering from chronic pain. DTM SCS therapy is a new proprietary SCS waveform that will be available on Medtronic Intellis platform.

Research Methodology

The market study of the global neurology devices market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Neurology Devices Market Research and Analysis, By Product
  • Global Neurology Devices Market Research and Analysis, By End-User
The Report covers:
  • Comprehensive research methodology of the global neurology devices market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global neurology devices market.
  • Insights about market determinants which are stimulating the global neurology devices market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Dispomedica GmbH
  • Magstim Co. Ltd.
  • Möller Medical GmbH
  • NeuroPace, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdowns
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic plc
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Abbott Laboratories
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Boston Scientific Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. B. Braun Melsungen AG
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Stryker Corp.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities

5. Market Segmentation
5.1. Global Neurology Devices Market by Product
5.1.1. Cerebrospinal Fluid Management Devices
5.1.2. Neurostimulation Devices
5.1.2.1. Deep Brain Stimulation
5.1.2.2. Spinal Cord Stimulation
5.1.2.3. Sacral Nerve Stimulation
5.1.2.4. Others
5.1.3. Interventional Neurology Devices
5.1.3.1. Aneurysm Coiling and Embolization
5.1.3.2. Neurothrombectomy Devices
5.1.3.3. Neurovascular Catheters
5.1.3.4. Cerebral Balloon Angioplasty &Stents
5.1.4. Neurosurgery Devices
5.1.4.1. Neuroendoscopes
5.1.4.2. Aneurysm Clips
5.1.4.3. Stereotactic Systems
5.1.4.4. Others
5.1.5. Others
5.2. Global Neurology Devices Market by End-User
5.2.1. Hospitals
5.2.2. Neurology Clinics
5.2.3. Ambulatory Surgical Centers (ASCs)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories
7.2. Allergan plc
7.3. Axonics Modulation Technologies, Inc.
7.4. B. Braun Melsungen AG
7.5. Boston Scientific Corp.
7.6. Dispomedica GmbH
7.7. Integra LifeSciences Holdings Corp.
7.8. Johnson & Johnson Services Inc.
7.9. LivaNova PLC
7.10. Magstim Co. Ltd.
7.11. Medtronic plc
7.12. Möller Medical GmbH
7.13. Natus Medical Inc.
7.14. NeuroPace, Inc.
7.15. Nevro Corp.
7.16. Nihon Kohden Corp.
7.17. Penumbra, Inc.
7.18. Saluda Medical Pty Ltd.
7.19. Smith & Nephew plc
7.20. Stryker Corp.
7.21. W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories
  • Allergan plc
  • Axonics Modulation Technologies, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Dispomedica GmbH
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson Services Inc.
  • LivaNova PLC
  • Magstim Co. Ltd.
  • Medtronic plc
  • Möller Medical GmbH
  • Natus Medical Inc.
  • NeuroPace, Inc.
  • Nevro Corp.
  • Nihon Kohden Corp.
  • Penumbra, Inc.
  • Saluda Medical Pty Ltd.
  • Smith & Nephew plc
  • Stryker Corp.
  • W. L. Gore & Associates, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll